Literature DB >> 11642011

Subacute toxicity of chitosan oligosaccharide in Sprague-Dawley rats.

S K Kim1, P J Park, H P Yang, S S Han.   

Abstract

A subacute oral toxicity study of chitosan oligosaccharide was performed in Sprague-Dawley rats of both sexes. Each 36 male and female rats were administered by gavage with 500, 1,000 and 2,000 mg/kg/day for 4 weeks (7 days/week), respectively. Examinations regarding clinical signs, body weights, hematological and biochemical parameters, and histopathological examinations were carried out. There were no significant differences in behavior or external appearance, body weight and food consumption between control and treated rats. In addition, no significant differences in urinalysis, hematology, blood biochemistry, relative organ weights and histopathological findings were found in both control and treated rats. In conclusion, it was suggested that subacute toxicity of chitosan oligosaccharide was low and the no-observed adverse effect level was considered to be over 2,000 mg/kg in rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642011     DOI: 10.1055/s-0031-1300113

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  9 in total

1.  Nanotechnology Applications to HIV Vaccines and Microbicides.

Authors:  Sandhya Boyapalle; Subhra Mohapatra; Shyam Mohapatra
Journal:  J Glob Infect Dis       Date:  2012-01

2.  Chitin Oligosaccharide Modulates Gut Microbiota and Attenuates High-Fat-Diet-Induced Metabolic Syndrome in Mice.

Authors:  Junping Zheng; Gong Cheng; Qiongyu Li; Siming Jiao; Cui Feng; Xiaoming Zhao; Heng Yin; Yuguang Du; Hongtao Liu
Journal:  Mar Drugs       Date:  2018-02-19       Impact factor: 5.118

Review 3.  Anti-Pathogenic Functions of Non-Digestible Oligosaccharides In Vitro.

Authors:  Mostafa Asadpoor; Casper Peeters; Paul A J Henricks; Soheil Varasteh; Roland J Pieters; Gert Folkerts; Saskia Braber
Journal:  Nutrients       Date:  2020-06-16       Impact factor: 5.717

Review 4.  Structural features, interaction with the gut microbiota and anti-tumor activity of oligosaccharides.

Authors:  Yulin Wu; Yinning Chen; Yingfang Lu; Huili Hao; Jun Liu; Riming Huang
Journal:  RSC Adv       Date:  2020-04-24       Impact factor: 4.036

Review 5.  Chitosan and Chitooligosaccharide: The Promising Non-Plant-Derived Prebiotics with Multiple Biological Activities.

Authors:  Zhiwei Guan; Qiang Feng
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

6.  Chitosan Oligosaccharide Supplementation Affects Immunity Markers in Ewes and Lambs during Gestation and Lactation.

Authors:  Marefa Jahan; Cara Wilson; Shawn McGrath; Nidhish Francis; Peter C Wynn; Yuguang Du; Bruce Allworth; Bing Wang
Journal:  Animals (Basel)       Date:  2022-09-28       Impact factor: 3.231

7.  Respiratory syncytial virus infection: from biology to therapy: a perspective.

Authors:  Shyam S Mohapatra; Richard F Lockey
Journal:  World Allergy Organ J       Date:  2008-02       Impact factor: 4.084

8.  The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis.

Authors:  Ugur Aydogdu; Alparslan Coskun; Ahmet Duran Atas; Onur Basbug; Zahid Tevfik Agaoglu
Journal:  Small Rumin Res       Date:  2019-09-27       Impact factor: 1.611

9.  Effects of Chitosan Oligosaccharide on Plasma and Hepatic Lipid Metabolism and Liver Histomorphology in Normal Sprague-Dawley Rats.

Authors:  Shing-Hwa Liu; Rui-Yi Chen; Meng-Tsan Chiang
Journal:  Mar Drugs       Date:  2020-08-02       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.